Gene | Characteristics | Total (N) | Odds ratio (OR) | P value |
---|---|---|---|---|
SLC25A5 | Age (≤ 50 vs. > 50) | 304 | 0.802 (0.574–1.109) | 0.188 |
BMI (≤ 25 vs. > 25) | 259 | 1.008 (0.716–1.425) | 0.963 | |
Menopause status (Pre vs. Peri and Post) | 231 | 0.900 (0.622–1.295) | 0.573 | |
Histological type (adenosquamous vs. squamous cell carcinoma) | 304 | 0.648 (0.430–0.975) | 0.037 | |
T stage (T1 and T2 vs. T3 and T4) | 241 | 0.576 (0.327–0.985) | 0.050 | |
N stage (N0 vs. N1) | 193 | 1.129 (0.763–1.670) | 0.540 | |
M stage (M0 vs. M1) | 126 | 1.515 (0.689–3.164) | 0.278 | |
Clinical stage (stage I and stage II vs. stage IV and stage III) | 297 | 0.926 (0.627–1.353) | 0.694 | |
Histologic grade (G1 and G2 vs. G4 and G3) | 272 | 0.944 (0.680–1.308) | 0.731 | |
Primary therapy outcome (SD and PR and CR vs. PD) | 217 | 1.688 (0.918–3.093) | 0.089 | |
Radiation therapy (yes vs. no) | 304 | 1.028 (0.745–1.417) | 0.865 |